Pregnancy intention and opioid use disorder treatment retention in the MOTHER study.
Opioid use disorder (OUD) during pregnancy challenges public health. This study examines how pregnancy intention affects OUD treatment. The primary exposure and outcome were pregnancy intention and treatment duration among MOTHER (Maternal Opioid Treatment: Human Experimental Research) participants (N = 175). Treatment durations were longer (21.3 vs. 16.3 weeks; p = .01) among intended (n = 29) compared to unintended (n = 146) pregnancy participants, but this was not significant in adjusted analyses. Unintended pregnancies intersect with OUD and may modify one's treatment outcomes. OUD treatment may be a setting to help women implement informed family planning choices. (Am J Addict 2018;XX:1-3).